Traduction de «smoking cessation » (Français → Néerlandais) :

TERMINOLOGIE

Blessures:dues à un fait de guerre classées en Y36.0-Y36.7 ou Y36.9 mais survenues après la cessation des hostilités | par explosion de bombes ou de mines posées au cours de faits de guerre, l'explosion étant survenue après la cessation des hostilités
letsel door explosie van bommen of mijnen geplaatst in de loop van oorlogshandelingen, indien de explosie plaatsvond na staken van vijandelijkheden | letsel door oorlogshandelingen geclassificeerd onder Y36.0-Y36.7 of Y36.9, maar na staken van vijandelijkheden

Fait de guerre survenu après la cessation des hostilités
oorlogshandelingen na staken van vijandelijkheden

TRADUCTIONS EN CONTEXTE

Smoking cessation is the most important lifestyle target for the prevention of stroke.4-6 All smokers should receive the urgent advice to stop smoking, and help in doing so is to be offered (Evidence level 1, see KCE report Vol. 1A).
Smoking cessation is the most important lifestyle target for the prevention of stroke.4-6 All smokers should receive the urgent advice to stop smoking, and help in doing so is to be offered (Evidence level 1, see KCE report Vol.

MeSH : Smoking Cessation ; Nicotine / therapy, drug therapy ; Bupropion ; Antidepressive Agents ; Behavior Therapy ; Counseling ; Cost-Benefit Analysis NLM classification : WM 290
MeSH : Smoking Cessation ; Nicotine / therapy, drug therapy ; Bupropion ; Nortriptyline ; Antidepressive Agents ; Behavior Therapy ; Counseling ; Cost-Benefit Analysis NLM classification : WM 290

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

23. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation.
23. Stead LF,.Lancaster T. Group behaviour therapy programmes for smoking cessation.

12. Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, et al. Lateterm smoking cessation despite initial failure: an evaluation of Bupropion sustained release, nicotine patch, combination therapy, and placebo.
12. Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, et al. Lateterm smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.
Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke [see comments].

Guidance on the use of nicotine replacement therapy (NRT) and Bupropion for smoking cessation, 2002.
Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation, 2002.